山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (7): 12-18.doi: 10.6040/j.issn.1671-7554.0.2022.1290
樊荣1,李彬彬1,2,马晓丽1,汪运山1,郏雁飞1
FAN Rong1, LI Binbin1,2, MA Xiaoli1, WANG Yunshan1, JIA Yanfei1
摘要: 目的 研究分化型胚胎软骨发育基因2(DEC2)和缺氧诱导因子-2α(HIF-2α)在胃癌中的表达以及与临床病理参数之间的关系。 方法 将胃癌细胞株MKN45和HGC27分为实验组(缺氧72h组)和对照组(常氧72 h组),检测各组细胞DEC2和HIF-2α mRNA及蛋白的表达;并在这两种胃癌细胞株中转染DEC2真核表达质粒,检测DEC2和HIF-2α蛋白水平的表达。另外,通过免疫组织化学染色的方法检测60例胃癌组织及相应的癌旁胃黏膜组织中DEC2和HIF-2α的表达,并分析其相关性。 结果 缺氧处理后DEC2的mRNA及蛋白表达明显低于对照组,而HIF-2α的表达高于对照组。过表达DEC2后,HIF-2α的表达降低。DEC2在胃癌组织中的表达显著低于癌旁胃黏膜组织(χ2=20.512,P<0.001),HIF-2α的表达则高于癌旁胃黏膜组织(χ2=11.172,P=0.001)。在胃癌组织中DEC2、HIF-2α的表达水平与肿瘤的浸润深度、淋巴结转移及临床分期显著相关。DEC2与HIF-2α的表达在胃癌组织中呈负相关(P<0.001)。 结论 DEC2在胃癌细胞及组织中低表达,HIF-2α在胃癌细胞及组织中高表达,两者呈负相关,且与肿瘤发展转移联系密切。
中图分类号:
| [1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] Thrift AP, El-Serag HB. Burden of gastric cancer [J]. Clin Gastroenterol Hepatol, 2020, 18(3): 534-542. [3] Roy S, Kumaravel S, Sharma A, et al. Hypoxic tumor microenvironment: implications for cancer therapy [J]. Exp Biol Med(Maywood), 2020, 245(13): 1073-1086. [4] 牟宏芳, 赵以览, 张晓静, 等. 缺氧及缺氧诱导因子对不同器官相关疾病调控的研究进展 [J]. 兰州大学学报(医学版), 2022, 48(5): 72-78. MOU Hongfang, ZHAO Yilan, ZHANG Xiaojing, et al. Research progress in the regulation of hypoxia and hypoxia-inducible factors in different organ-related diseases [J]. Journal of Lanzhou University(Medical Sciences), 2022, 48(5): 72-78. [5] 曹悦悦, 吴雪琼, 赵思文, 等. 转录调节因子DEC2和肿瘤的研究进展[J]. 现代肿瘤医学, 2015, 23(7): 1002-1004. CAO Yueyue, WU Xueqiong, ZHAO Siwen, et al. A review of a transcriptional regulation factor DEC2 and tumor [J]. Journal of Modern Oncology, 2015, 23(7): 1002-1004. [6] Yang X, Wu JS, Li M, et al. Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma [J]. J Exp Clin Cancer Res, 2021, 40(1): 169. [7] 曹毛毛, 李贺, 孙殿钦, 等. 2000—2019年中国胃癌流行病学趋势分析[J]. 中华消化外科杂志, 2021, 20(1): 102-109. CAO Maomao, LI He, SUN Dianqin, et al. Epidemiological trend analysis of gastric cancer in China from 2000 to 2019 [J]. Chinese Journal Digestive Surgery, 2021, 20(1): 102-109. [8] Lei ZN, Teng Q X, Tian Q, et al. Signaling pathways and therapeutic interventions in gastric cancer [J]. Signal Transduct Target Ther, 2022, 7(1): 358. [9] Hirano A, Hsu PK, Zhang L, et al. DEC2 modulates orexin expression and regulates sleep [J]. Proc Natl Acad Sci U S A, 2018, 115(13): 3434-3439. [10] Sato F, Kohsaka A, Bhawal UK, et al. Potential roles of Dec and Bmal1 genes in interconnecting circadian clock and energy metabolism [J]. Int J Mol Sci, 2018, 19(3):781. [11] De Martin X, Sodaei R, Santpere G. Mechanisms of binding specificity among bHLH transcription factors [J]. Int J Mol Sci, 2021, 22(17): 9150. doi: 10.3390/ijms22179150. [12] Zhang D, Zheng Q, Wang C, et al. BHLHE41 suppresses MCF-7 cell invasion via MAPK/JNK pathway [J]. J Cell Mol Med, 2020, 24(7): 4001-4010. [13] Nagata T, Minami K, Yamamoto M, et al. BHLHE41/DEC2 expression induces autophagic cell death in lung cancer cells and is associated with favorable prognosis for patients with lung adenocarcinoma [J]. Int J Mol Sci, 2021, 22(21): 11509. doi: 10.3390/ijms222111509. [14] Bigot P, Colli LM, Machiela MJ, et al. Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41 [J]. Nat Commun, 2016, 7: 12098. doi: 10.1038/ncomms12098. [15] Numata A, Kwok HS, Kawasaki A, et al. The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia [J]. Nat Commun, 2018, 9(1): 1622. doi: 10.1038/s41467-018-03854-0. [16] Liu Q, Wu Y, Yoshizawa T, et al. Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells [J]. Int J Molr Med, 2016, 38(6): 1727-1733. [17] Li P, Jia YF, Ma XL, et al. DEC2 suppresses tumor proliferation and metastasis by regulating ERK/NF-κB pathway in gastric cancer [J]. Am J Cancer Res, 2016, 6(8): 1741-1757. [18] Parks SK, Cormerais Y, Pouysségur J. Hypoxia and cellular metabolism in tumour pathophysiology [J]. J Physiol, 2017, 595(8): 2439-2450. [19] Liao Y, Lu W, Che Q, et al. SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level [J]. PLoS One, 2014, 9(6): e99907. doi: 10.1371/journal.pone.0099907. [20] Chen S, Dong QJ, Wan ZA, et al. BHLHE41 overexpression alleviates the malignant behavior of colon cancer cells induced by hypoxia via modulating HIF-1α/EMT pathway [J]. Gastroenterol Res Pract, 2022, 2022: 6972331. doi: 10.1155/2022/6972331. [21] Kusunose N, Akamine T, Kobayashi Y, et al. Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial(Müller)cells [J]. Jap J Ophthalmol, 2018, 62(6): 677-685. [22] Befani C, Liakos P. The role of hypoxia-inducible factor-2 alpha in angiogenesis [J]. J Cell Physiol, 2018, 233(12): 9087-9098. [23] Murugesan T, Rajajeyabalachandran G, Kumar S, et al. Targeting HIF-2α as therapy for advanced cancers [J]. Drug Discov Today, 2018, 23(7): 1444-1451. [24] Wang Y, Li Z, Zhang H, et al. HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer [J]. Cancer Biol Ther, 2010, 10(4): 376-382. [25] Tong WW, Tong GH, Chen XX, et al. HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 in gastric carcinoma [J]. Int J Oncol, 2015, 46(1): 233-242. [26] Griffiths EA, Pritchard SA, Mcgrath SM, et al. Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis [J]. Br J Cancer, 2008, 98(5): 965-973. [27] Wu Y, Sato H, Suzuki T, et al. Involvement of c-Myc in the proliferation of MCF-7 human breast cancer cells induced by bHLH transcription factor DEC2 [J]. Int J Mol Med, 2015, 35(3): 815-820. |
| [1] | 黄方 康瑞 吴春林. VEGFC、NF-κBp65及Survivin在鼻咽癌中的表达及临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 83-. |
| [2] | 张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84. |
| [3] | 曲忠花,迟令懿,马志勇,程振英,王旭平. 缺氧条件下γ-氨基丁酸能系统对视网膜色素上皮的保护作用[J]. 山东大学学报 (医学版), 2025, 63(12): 96-104. |
| [4] | 陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71. |
| [5] | 郭振江,王宁,赵光远,杜立强,崔朝勃,刘防震. 基于机器学习建立术前预测近端胃癌食管切缘阳性模型[J]. 山东大学学报 (医学版), 2024, 62(7): 78-83. |
| [6] | 魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94. |
| [7] | 刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30. |
| [8] | 郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47. |
| [9] | 吴霖,石晨曦,童星. 肺良性转移性平滑肌瘤病7例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(4): 78-84. |
| [10] | 孙菁果,朱文帅,鲁艺,马晓丽,郏雁飞. 幽门螺杆菌感染对胃癌细胞m6A水平的影响及其机制[J]. 山东大学学报 (医学版), 2023, 61(9): 10-18. |
| [11] | 穆彦熹,李金洲,陈康,梁红英,姚亚龙,汪文杰,陈晓. 443例胃癌根治术后发生肺部并发症的危险因素[J]. 山东大学学报 (医学版), 2023, 61(4): 37-41. |
| [12] | 郭崇勇,赵朋,刘海盟,王强, 贾宗师,张建. 胸前丘疹为首发表现的胃癌1例[J]. 山东大学学报 (医学版), 2023, 61(4): 119-120. |
| [13] | 王赞,徐晓涵,张瑜,曲业敏,王明义,陈艾. 幽门螺杆菌感染对胃癌细胞糖酵解的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 16-24. |
| [14] | 华月帆,何珂瑶,张家豪,钱梦凡,刘怡文,孔金玉,杨海军,周福有. 具核梭杆菌诱导缺氧诱导因子及血管生成因子高表达对食管鳞癌患者生存预后的影响[J]. 山东大学学报 (医学版), 2023, 61(11): 59-67. |
| [15] | 付佳,王路路,胡帅,陈哲平,刘东义,李青松,卢国栋,张贺,赵鑫,冯昌. 不同入路腰方肌阻滞对胃癌根治患者术后恢复的影响[J]. 山东大学学报 (医学版), 2022, 60(8): 50-57. |
|
||